[Federal Register Volume 84, Number 147 (Wednesday, July 31, 2019)]
[Notices]
[Pages 37323-37324]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16306]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Council on Blood Stem Cell
Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Council on Blood Stem Cell
Transplantation (ACBSCT) has scheduled a public meeting. Information
about ACBSCT and the agenda for this meeting will be available on the
ACBSCT website at https://bloodcell.transplant.hrsa.gov/about/advisory_council/meetings/index.html.
DATES: September 10, 2019, 10:00 a.m.-4:00 p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held by webinar. Members of the public
can access the webinar link and conference call-in number at https://bloodcell.transplant.hrsa.gov/about/advisory_council/meetings/index.html.
FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal
Official, (DFO), at Division of Transplantation, Healthcare Systems
[[Page 37324]]
Bureau, HRSA, 5600 Fishers Lane, 8W60, Rockville, Maryland 20857; 301-
443-6839; or [email protected].
SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations
to the Secretary of HHS (Secretary) and the HRSA Administrator on the
activities of the C.W. Bill Young Cell Transplantation Program and the
National Cord Blood Inventory Program. The principal purpose of these
programs is to make blood stem cells from adult donors and cord blood
units available for patients who need a transplant to treat life-
threatening conditions such as leukemia, and who lack a suitably
matched relative who can be the donor.
During the September 10, 2019, meeting, ACBSCT will discuss issues
related to utilization of cord blood for transplant and utilization of
blood stem cells in cellular therapies. Agenda items are subject to
change as priorities dictate. Refer to the ACBSCT website for any
updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to ACBSCT must be sent
to Robert Walsh, DFO, using the contact information above at least
three business days before the meeting.
Individuals who plan to participate in the webinar and need special
assistance or other reasonable accommodations should notify Robert
Walsh at the address and phone number listed above at least 10 business
days before the meeting.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-16306 Filed 7-30-19; 8:45 am]
BILLING CODE 4165-15-P